Evinacumab Reduces Lipids, Cholesterol in Hypercholsterolemia and Hypertriglyceridemia

Data from a meta-analysis of evinacumab trials reveal significant reductions in cholesterol and other lipid markers among patients with dyslipidemia.

Related Keywords

Linkedin Muhammad Saqlain Mustafa ,Robert Rosenson ,Muhammad Saqlain Mustafa ,Aga Khan University Hospital ,Drug Administration ,Regeneron Pharmaceuticals Inc ,Cardiometabolic Disorders ,Icahn School ,Treating Hypercholesterolemia ,Systematic Review ,Randomized Controlled ,Drug Evaluation ,